Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-23 Purchase |
2021-03-25 6:05 pm |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
882,351 | $17 | $14,999,967 | 882,351 (Indirect) |
View |
| 2021-03-23 Purchase |
2021-03-25 6:04 pm |
Finch Therapeutics Group Inc. | FNCH | FERRANTE DOMENIC J Director |
102,941 | $17 | $1,749,997 | 636,195 (Indirect) |
View |
| 2021-03-23 Purchase |
2021-03-25 6:01 pm |
Finch Therapeutics Group Inc. | FNCH | Crestovo Investor LLC Shumway Chris Director 10% Owner |
735,294 | $17 | $12,499,998 | 12,641,441 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-23 Conversion |
2021-03-25 6:05 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
3,110,706 | $0 | 882,351 (Indirect) |
View |
| 2021-03-23 Conversion |
2021-03-25 6:04 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | FERRANTE DOMENIC J Director |
533,254 | $0 | 636,195 (Indirect) |
View |
| 2021-03-23 Conversion |
2021-03-25 6:01 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Crestovo Investor LLC Shumway Chris Director 10% Owner |
23,812,294 | $0 | 12,641,441 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-18 9:33 pm |
N/A 2031-03-17 |
Finch Therapeutics Group Inc. | FNCH | Vittiglio Joseph General Counsel and Secretary |
95,194 | $0 | 95,194 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-18 9:31 pm |
N/A 2031-03-17 |
Finch Therapeutics Group Inc. | FNCH | Smith Mark Burnham Chief Executive Officer |
595,402 | $0 | 595,402 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-18 9:30 pm |
N/A 2031-03-17 |
Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer |
55,386 | $0 | 55,386 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-18 9:30 pm |
N/A 2031-03-17 |
Finch Therapeutics Group Inc. | FNCH | Kassam Zain Chief Medical Officer |
69,232 | $0 | 69,232 (Direct) |
View |
Ownership |
2021-03-18 9:25 pm |
N/A 2031-02-07 |
Finch Therapeutics Group Inc. | FNCH | Vittiglio Joseph General Counsel and Secretary |
0 | $0 | 60,578 (Direct) |
View |
Ownership |
2021-03-18 9:22 pm |
N/A 2030-04-06 |
Finch Therapeutics Group Inc. | FNCH | Viney Joanne L. Director |
0 | $0 | 13,846 (Direct) |
View |
Ownership |
2021-03-18 9:21 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Smith Mark Burnham Chief Executive Officer |
0 | $0 | 1,903,033 (Direct) |
View |
Ownership |
2021-03-18 9:20 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | SMISEK JEFFERY A Director |
0 | $0 | 1,606,306 (Indirect) |
View |
Ownership |
2021-03-18 9:19 pm |
N/A 2028-05-06 |
Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer |
0 | $0 | 304,254 (Direct) |
View |
Ownership |
2021-03-18 9:19 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Kassam Zain Chief Medical Officer |
0 | $0 | 1,330,351 (Direct) |
View |
Ownership |
2021-03-18 9:18 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Crestovo Investor LLC Shumway Chris Director 10% Owner |
0 | $0 | 11,906,147 (Direct) |
View |
Ownership |
2021-03-18 9:18 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
0 | $0 | 3,110,706 (Indirect) |
View |
Ownership |
2021-03-18 9:16 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | FERRANTE DOMENIC J Director |
0 | $0 | 533,254 (Indirect) |
View |